Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Evolus Inc., 3 years.
Evolus Inc.
Director
Arcturus Therapeutics Holdings Inc.
Director
ResMed Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | ResMed Inc. | Open-market sale | −8,000 | $225.00 | $1,800,000 |
| Apr 1, 2026 | ResMed Inc. | Open-market sale | −2,000 | $225.00 | $450,000 |
| Mar 4, 2026 | ResMed Inc. | Open-market sale | −2,000 | $260.22 | $520,440 |
| Feb 4, 2026 | ResMed Inc. | Open-market sale | −2,000 | $251.31 | $502,620 |
| Jan 7, 2026 | ResMed Inc. | Open-market sale | −2,000 | $248.83 | $497,660 |
| Dec 3, 2025 | ResMed Inc. | Open-market sale | −2,000 | $251.47 | $502,940 |
| Nov 20, 2025 | ResMed Inc. | Grant or award | +536 | — | — |
| Nov 14, 2025 | ResMed Inc. | Option exercise | +11,442 | $101.64 | $1,162,965 |
| Nov 14, 2025 | ResMed Inc. | Shares withheld for tax | −7,314 | $244.46 | $1,787,980 |
| Nov 12, 2025 | ResMed Inc. | Open-market sale | −2,000 | $252.05 | $504,100 |
| Nov 11, 2025 | ResMed Inc. | Shares withheld for tax | −163 | $250.10 | $40,754 |
| Jul 2, 2025 | ResMed Inc. | Open-market sale | −945 | $255.49 | $241,438 |
| Jun 4, 2025 | ResMed Inc. | Open-market sale | −2,000 | $247.32 | $494,640 |
| May 7, 2025 | ResMed Inc. | Open-market sale | −2,000 | $242.25 | $484,500 |
| Apr 2, 2025 | ResMed Inc. | Open-market sale | −2,000 | $219.74 | $439,480 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.